A Rosetta stone for insulin treatment: Self-monitoring of blood glucose

Clinical Chemistry

Volumn 50, Issue 6, 2004, Pages 985-987

  Winter, William E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; RECOMBINANT HUMAN INSULIN;

ACCURACY; ANALYTIC METHOD; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIET; EDITORIAL; EXERCISE; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GOVERNMENT; HEALTH CARE PERSONNEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROBLEM SOLVING; TREATMENT OUTCOME;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT EDUCATION; POINT-OF-CARE SYSTEMS;

EID: 2642553860     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.033167     Document Type: Editorial

References (29)

1. Blake DR, Nathan DM. Point-of-care testing for diabetes. Point of Care 2002;1:155-64.
2. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, et al.; Diabetes Outcomes In Veterans Study (DOVES). Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003;26:1759-63.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
5. American Diabetes Association. Implications of the diabetes control and complications trial. Diabetes Care 2003;26:S25-32.
6. Winter WE, Harris NS. Self-monitoring of blood glucose: needless expense or a vital glycemic monitor? Point of Care 2003;2:62-8.
7. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, et al.; ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-94.
8. Schwedes U, Siebolds M, Mertes G; SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25:1928-32.
9. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2004 27:S91-3.
10. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27:S15-35.
11. Kappy MS, Bajaj L. Recognition and treatment of endocrine/metabolic emergencies in children: part I. Adv Pediatr 2002;49:245-72.
12. Kristensen GBB, Nerhus K, Thue G, Sandberg S. Standardized evaluation of instruments for self-monitoring of glucose by patients and a technologist. Clin Chem 2004;50:1068-71.
13. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 2002;48:994-1003.
14. Thayer A. Deciphering diseases. Chem Eng News 1999;30:19-28.
15. Bergenstal R, Pearson J, Cembrowski GS, Bina D, Davidson J, List S. Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. Diabetes Educ 2000;26:981-9.
16. Borg Andersson A, Birkhed D, Berntorp K, Lindgarde F, Matsson L. Glucose concentration in parotid saliva after glucose/food intake in individuals with glucose intolerance and diabetes mellitus. Eur J Oral Sci 1998;106:931-7.
17. Reuterving CO, Reuterving G, Hagg E, Ericson T. Salivary flow rate and salivary glucose concentration in patients with diabetes mellitus influence of severity of diabetes. Diabetes Metab 1987;13:457-62.
18. Ginsberg BH. An overview of minimally invasive technologies. Clin Chem 1992;38:1596-600.
19. Tierney MJ, Tamada JA, Potts RO, Eastman RC, Pitzer K, Ackerman NR, et al. the GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor. Ann Med 2000;32:632-41.
20. Mastrototaro J. The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 1999;12(Suppl 3):751-8.
21. Borchert MS, Storrie-Lombardi MC, Lambert JL. A noninvasive glucose monitor: preliminary results in rabbits. Diabetes Technol Ther 1999;1:145-51.
22. March WF. A noninvasive ocular glucose sensor. Diabetes Technol Ther 2001;3:209-10.
23. Cameron BD, Baba JS, Cote GL. Measurement of the glucose transport time delay between the blood and aqueous humor of the eye for the eventual development of a noninvasive glucose sensor. Diabetes Technol Ther 2001;3:201-7.
24. Geffken G, Winter WE. Hardware and software in diabetes mellitus: performance characteristics of hand-held glucose testing devices and the application of glycemic testing to patients' daily diabetes management. Clin Chem 2001;47:11-2.
25. Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, et al. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD Study. Diabetes Metab 2001;27:681-7.
26. Skeie S, Thue G, Sandberg S. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clin Chem 2001;47:67-73.
27. Alto WA, Meyer D, Schneid J, Bryson P, Kindig J. Assuring the accuracy of home glucose monitoring. J Am Board Fam Pract 2002;15:1-6.
28. US Food and Drug Administration. Department of Health and Human Services. Diabetes information. http://www.fda.gov/diabetes/glucose.html (accessed March 29, 2004).
29. The American Diabetes Association Channel. A guide to checking your blood sugar. http://www.diabetes.org/all-about-diabetes/chan_eng/i5/i5p1.htm (accessed March 29, 2004).